Your browser doesn't support javascript.
loading
Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by 18F-Misonidazole PET/CT in Patients with Non-Small Cell Lung Carcinoma (RTEP5 Study).
Vera, Pierre; Thureau, Sébastien; Chaumet-Riffaud, Philippe; Modzelewski, Romain; Bohn, Pierre; Vermandel, Maximilien; Hapdey, Sébastien; Pallardy, Amandine; Mahé, Marc-André; Lacombe, Marie; Boisselier, Pierre; Guillemard, Sophie; Olivier, Pierre; Beckendorf, Veronique; Salem, Naji; Charrier, Nathalie; Chajon, Enrique; Devillers, Anne; Aide, Nicolas; Danhier, Serge; Denis, Fabrice; Muratet, Jean-Pierre; Martin, Etienne; Riedinger, Alina Berriolo; Kolesnikov-Gauthier, Helène; Dansin, Eric; Massabeau, Carole; Courbon, Fredéric; Farcy Jacquet, Marie-Pierre; Kotzki, Pierre-Olivier; Houzard, Claire; Mornex, Francoise; Vervueren, Laurent; Paumier, Amaury; Fernandez, Philippe; Salaun, Mathieu; Dubray, Bernard.
Afiliación
  • Vera P; Department of Nuclear Medicine, Henri Becquerel Cancer Center and Rouen University Hospital & QuantIF-LITIS, University of Rouen, Rouen, France pierre.vera@chb.unicancer.fr.
  • Thureau S; Department of Radiation Oncology and Medical Physics, Henri Becquerel Cancer Center and Rouen University Hospital & QuantIF-LITIS, Rouen, France.
  • Chaumet-Riffaud P; Department of Nuclear Medicine, Hôpitaux universitaires Paris Sud Bicêtre AP-HP and University Paris Sud, Paris, France.
  • Modzelewski R; Department of Nuclear Medicine, Henri Becquerel Cancer Center and Rouen University Hospital & QuantIF-LITIS, University of Rouen, Rouen, France.
  • Bohn P; Department of Nuclear Medicine, Henri Becquerel Cancer Center and Rouen University Hospital & QuantIF-LITIS, University of Rouen, Rouen, France.
  • Vermandel M; University Lille, Inserm, CHU Lille, U1189-ONCO-THAI-Image Assisted Laser Therapy for Oncology, Lille, France.
  • Hapdey S; Department of Nuclear Medicine, Henri Becquerel Cancer Center and Rouen University Hospital & QuantIF-LITIS, University of Rouen, Rouen, France.
  • Pallardy A; Department of Nuclear Medicine, Nantes University Hospital, Nantes, France.
  • Mahé MA; Department of Radiation Oncology, Institut de Cancérologie de l'Ouest (ICO)-René Gauducheau, Nantes, France.
  • Lacombe M; Department of Nuclear Medicine, Institut de Cancérologie de l'Ouest (ICO), Nantes, France.
  • Boisselier P; Department of Radiation Oncology, Institut régional du Cancer Montpellier (ICM), Montpellier, France.
  • Guillemard S; Department of Nuclear Medicine, Institut régional du Cancer Montpellier (ICM), Montpellier, France.
  • Olivier P; Department of Nuclear Medicine, Brabois University Hospital, Nancy, France.
  • Beckendorf V; Department of Radiation Oncology, Institut de Cancérologie de Lorraine, Nancy, France.
  • Salem N; Department of Radiation Oncology, Institut Paoli Calmette, Marseille, France.
  • Charrier N; Department of Nuclear Medicine, Institut Paoli Calmette, Marseille, France.
  • Chajon E; Department of Radiation Oncology, Centre regional de lutte contre le cancer de Bretagne Eugène Marquis, Rennes, France.
  • Devillers A; Department of Nuclear Medicine, Centre regional de lutte contre le cancer de Bretagne Eugène Marquis, Rennes, France.
  • Aide N; Nicolas Aide, Nuclear Medicine and TEP Centre, Caen University Hospital and Inserm U1086 ANTICIPE, Caen, France.
  • Danhier S; Department of Radiation Oncology, François Baclesse Cancer Center, Caen, France.
  • Denis F; Department of Radiation Oncology, Institut Inter-Régional de Cancérologie (ILC), Centre Jean Bernard/Clinique Victor Hugo, Le Mans, France.
  • Muratet JP; Department of Nuclear Medicine, Institut Inter-Régional de Cancérologie (ILC), Centre Jean Bernard/Clinique Victor Hugo, Le Mans, France.
  • Martin E; Radiation Oncology, Centre Georges-Francois Leclerc, Dijon, France.
  • Riedinger AB; Department of Nuclear Medicine, Centre Georges Francois Leclerc, Dijon, France.
  • Kolesnikov-Gauthier H; Department of Nuclear Medicine, Oscar Lambret Center, Lille cedex, France.
  • Dansin E; Department of Radiation Oncology, Oscar Lambret Center, Lille cedex, France.
  • Massabeau C; Département de Radiothérapie. Institut Universitaire du Cancer, Toulouse cedex 9, France.
  • Courbon F; Department of Nuclear Medicine, Institut Claudius Regaud, IUCT, Toulouse cedex 9, France.
  • Farcy Jacquet MP; Department of Radiation Oncology, CHU de Nîmes, Institut de cancérologie du Gard, Rue Henri Pujol, Nîmes, France.
  • Kotzki PO; Department of Nuclear Medicine, Institut régional du Cancer Montpellier (ICM), Montpellier, France.
  • Houzard C; Department of Nuclear Medicine, CHU de Nîmes, Institut de cancérologie du Gard, Nîmes, France.
  • Mornex F; Department of Nuclear Medicine, Hospices Civils de Lyon, Lyon, France.
  • Vervueren L; Department of Radiation Oncology, Hospices Civils de Lyon, Lyon, France.
  • Paumier A; Department of Nuclear Medicine, CHU Angers, France.
  • Fernandez P; Department of Radiation Oncology, Institut de Cancérologie de l'Ouest, site Paul Papin, France.
  • Salaun M; Department of Nuclear Medicine, Hôpital Pellegrin, CHU de Bordeaux, France; and.
  • Dubray B; Normandy University, UNIROUEN, QuantIF-LITIS EA 4108, Rouen University Hospital, Department of Pulmonology-Thoracic Oncology-Respiratory Intensive Care, Rouen, France.
J Nucl Med ; 58(7): 1045-1053, 2017 07.
Article en En | MEDLINE | ID: mdl-28254869
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Fraccionamiento de la Dosis de Radiación / Neoplasias Pulmonares / Misonidazol Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Nucl Med Año: 2017 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Fraccionamiento de la Dosis de Radiación / Neoplasias Pulmonares / Misonidazol Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Nucl Med Año: 2017 Tipo del documento: Article País de afiliación: Francia